SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
GARDNER, Mass., Feb. 11, 2016 -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") announced that it intends to release its financial results for the fiscal 2016 second quarter ended December 31, 2015 after market trading ends on Tuesday, February 16, 2016.
Management has scheduled a conference call for 4:30 p.m. ET on Wednesday, February 17th to review the Company's financial results and future outlook. Participants may dial into the following number to access the call: 1-866-652-5200 or 1-412-317-6060. Please ask to be joined into the Precision Optics conference call. A replay of the call can be accessed at 1-877-344-7529 or 1-412-317-0088 and passcode: 10081171 until March 2, 2016.
About Precision Optics Corporation
Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for a broad range of customers including some of the largest world-wide medical device companies. The Company's innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company's website is www.poci.com. Investors can find Real-Time Quotes and market information for the Company on www.otcmarkets.com/stock/PEYE/quote.
Company Contact: PRECISION OPTICS CORPORATION 22 EAST BROADWAY GARDNER, MASSACHUSETTS 01440-3338 Telephone: 978-630-1800 Investor Contact: Kirin M. Smith, Chief Operating Officer PCG Advisory Group D: 646.863.6519 E: [email protected] www.pcgadvisory.com
